Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study

Background Circulating tumor cells (CTCs) and chemokine (C-X-C motif) receptor 4 (CXCR4) expression in CTCs and tumor tissue were evaluated as prognostic or predictive markers of CXCR4 peptide antagonist LY2510924 plus carboplatin-etoposide (CE) versus CE in extensive-stage disease small cell lung c...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Invest New Drugs
Main Authors: Salgia, Ravi, Weaver, R. Waide, McCleod, Michael, Stille, John R., Yan, S. Betty, Roberson, Stephanie, Polzer, John, Flynt, Amy, Raddad, Eyas, Peek, Victoria L., Wijayawardana, Sameera R., Um, Suzane L., Gross, Steve, Connelly, Mark C., Morano, Carrie, Repollet, Madeline, Sanders, Renouard, Baeten, Kurt, D’Haese, David, Spigel, David R.
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer US 2017
נושאים:
Phase II Studies
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5418321/
https://ncbi.nlm.nih.gov/pubmed/28299514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-017-0446-z
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים